ARTICLE | Company News
Cubist, Evotec deal
July 20, 2009 7:00 AM UTC
Evotec will use its EVOlution fragment-based drug discovery platform and its internal crystallography platform to identify compounds against two antibacterial targets chosen by Cubist. Further terms w...